MedTrace Logo

5 Versus 10 Units of Insulin in Hyperkalemia Management

NCT06036823 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 384

Last updated 2025-12-22

No results posted yet for this study

Summary

The goal of this study is to compare 5 units of intravenous Regular insulin to 10 units of intravenous regular insulin in the management of hyperkalemia. We will measure the efficacy of these 2 doses of insulin in reducing hyperkalemia at 2 hours from administration using the main laboratory serum values.

Conditions

  • Hyperkalemia
  • Potassium Imbalance
  • Electrolyte Imbalance
  • Electrolyte Disturbance

Interventions

DRUG

Insulin regular

Intravenous insulin

DRUG

Dextrose 50

to be given to both arms

DRUG

salbutamol

to be given to all patients

Sponsors & Collaborators

  • Sultan Qaboos University

    collaborator OTHER

  • Oman Medical Speciality Board

    lead OTHER_GOV

Principal Investigators

  • Suad Al-Abri · Sultan Qaboos University hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Oman

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06036823 on ClinicalTrials.gov